Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Legend Biotech Corp ADR (NASDAQ: LEGN) closed at $35.12 down -1.04% from its previous closing price of $35.49. In other words, the price has decreased by -$1.04 from its previous closing price. On the day, 0.89 million shares were traded. LEGN stock price reached its highest trading level at $36.0 during the session, while it also had its lowest trading level at $34.95.
Ratios:
For a deeper understanding of Legend Biotech Corp ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.90 and its Current Ratio is at 4.98. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on October 08, 2024, initiated with a Buy rating and assigned the stock a target price of $86.
On June 17, 2024, Truist started tracking the stock assigning a Buy rating and target price of $88.
H.C. Wainwright reiterated its Buy rating for the stock on May 24, 2024, while the target price for the stock was revised from $86 to $73.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 02 ’24 when Heyman Tomas J. bought 4,366 shares for $43.31 per share.
Huang Ying bought 1,504 shares of LEGN for $66,326 on Sep 25 ’24. On Sep 20 ’24, another insider, Macomber Lori, who serves as the Officer of the company, bought 90,060 shares for $48.91 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LEGN now has a Market Capitalization of 6442763776 and an Enterprise Value of 12019753984. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.39 while its Price-to-Book (P/B) ratio in mrq is 5.77. Its current Enterprise Value per Revenue stands at 23.107 whereas that against EBITDA is -35.294.
Stock Price History:
Over the past 52 weeks, LEGN has reached a high of $70.13, while it has fallen to a 52-week low of $35.16. The 50-Day Moving Average of the stock is -17.94%, while the 200-Day Moving Average is calculated to be -28.63%.
Shares Statistics:
For the past three months, LEGN has traded an average of 1.41M shares per day and 1355320 over the past ten days. A total of 183.45M shares are outstanding, with a floating share count of 181.93M. Insiders hold about 0.83% of the company’s shares, while institutions hold 49.50% stake in the company. Shares short for LEGN as of 1732838400 were 23805759 with a Short Ratio of 16.93, compared to 1730332800 on 15858425. Therefore, it implies a Short% of Shares Outstanding of 23805759 and a Short% of Float of 24.790001.
